Adaptive high frequency chest wall oscillation system

Abstract

The present disclosure relates to devices, systems, and methods for high frequency chest wall oscillation (HFCWO) therapy that can enhance mucus clearance by preferentially impacting a user, including by continuously applying pressure to a chest engagement device to provide HFCWO. Chest wall oscillation therapy systems of the present disclosure can include a chest engagement device for transmitting an impact force to a patient's chest and a force generator arranged to generate a continuous impact force as a patient therapy regimen. The chest wall oscillation therapy system additionally includes a therapy control system including at least one sensor arranged to detect an indication of a patient's breathing pattern.

Description

Technical Field

[0001] This disclosure relates to an apparatus, system, and method for chest wall treatment. More specifically, this disclosure relates to an apparatus, system, and method for high-frequency chest wall oscillation (HFCWO) treatment. Background Technology

[0002] High-frequency concussive impact on the patient's chest wall can promote the drainage of mucus from the upper respiratory tract. For example, HFCWO treatment has successfully cured patients with mucus accumulation, such as those with cystic fibrosis. However, this impact may cause discomfort to the patient and / or may lead to inefficient forceful mucus drainage. Summary of the Invention

[0003] This application discloses one or more features recited in the appended claims and / or the following features, which may individually or in any combination comprise patentable subject matter.

[0004] According to one aspect of this disclosure, a chest wall concussion therapy system may include: a chest engagement device for transmitting impact force to a patient's chest; a force generator arranged to generate continuous impact force as a treatment protocol for the patient, the force generator being arranged in communication with the chest engagement device to transmit the impact force from the force generator to the patient's chest to facilitate airway clearance; and a treatment control system. The treatment control system may include at least one sensor arranged to detect indications of the patient's breathing pattern.

[0005] In some embodiments, at least one sensor may include at least one microelectromechanical sensor. At least one sensor may be arranged to provide at least nine-axis tracking of the patient's chest movements. At least one sensor may include at least one accelerometer. At least one sensor may include at least one gyroscope. At least one sensor may include at least one magnetometer.

[0006] In some embodiments, the treatment control system may include at least one processor for providing motion structures based on data received from at least one sensor. At least one sensor may be mounted to the chest engagement device to detect patient chest movements. The treatment control system may be configured to communicate with a personal mobile device to convey patient chest indications.

[0007] In some embodiments, the treatment control system may be arranged to configure a force generator treatment program based on data from at least one sensor. The treatment control system may configure the force generator treatment program to increase at least one of the oscillation rate and intensity during patient exhalation. The treatment control system may configure the therapeutic force generator to have an expiratory setting for at least one of the oscillation frequency and impact intensity during patient exhalation, which is greater than a predetermined nominal setting for at least one of the oscillation frequency and impact intensity. The treatment control system may configure the therapeutic force generator to have an inspiratory setting for at least one of the oscillation frequency and impact intensity during patient inhalation, which is less than the expiratory setting during patient exhalation. The inspiratory setting may be less than or equal to a predetermined nominal setting.

[0008] In some embodiments, the treatment control system may configure the force generator treatment program to reduce at least one of the oscillation rate and intensity during patient inhalation. The treatment control system may configure the therapeutic force generator to have an inhalation setting for at least one of the oscillation frequency and impact intensity during patient inhalation, which is less than a predetermined nominal setting for at least one of the oscillation frequency and impact intensity. The treatment control system may configure the therapeutic force generator to have an expiratory setting for at least one of the oscillation frequency and impact intensity during patient exhalation, which is greater than the inhalation setting during patient inhalation. The expiratory setting may be greater than or equal to the predetermined nominal setting.

[0009] In some embodiments, the treatment control system may include a graphical user interface for communicating with a user. The graphical user interface may be arranged to present optional options selectable by the user. The optional options selectable by the user may include a vibration start button for initiating operation to deliver an impact force to the patient.

[0010] In some embodiments, in response to a user selecting the vibration start button, the graphical user interface may present a pause button as an optional option. Optional options available to the user may include a new pre-defined treatment plan button, allowing the user to create a new pre-defined treatment plan for implementation. Optional options available to the user may include an unlock button. In response to a user selecting the unlock button, at least one of a frequency button, an intensity button, and a time button may be presented as optional options to configure the corresponding features.

[0011] In some embodiments, optional options available to the user include a Pre-selected Treatment Plan tab for implementing a pre-selected treatment plan as a treatment plan. In response to the user selecting at least one of the Pre-selected Treatment Plan tab and the Unlock button, a Cough Pause tab may be presented for the user to select to configure cough pause settings for the pre-selected treatment plan. In response to the user selecting the Cough Pause tab, at least one of a Cough Pause Enable switch and / or an Auto Restart switch may be presented for the user to select. In some embodiments, optional options may include a pull-tab tab for user activation to present additional optional options. Additional optional options may include at least one of a Home button, a Cough Pause Settings button, and a Delete Treatment button.

[0012] In some embodiments, in response to a user selecting a cough pause enable switch to confirm cough cessation, at least one of a pause duration button and a pause frequency button may be presented for the user to select to adjust the associated enable switch and auto-restart switch for the user to select to configure the corresponding features. The chest fitting device may include wearable clothing.

[0013] According to another aspect of this disclosure, a chest wall concussion therapy system may include: a chest engagement device for transmitting impact force to a patient's chest; a force generator arranged to generate continuous impact force as a treatment protocol for the patient, the force generator being arranged in communication with the chest engagement device to transmit the impact force from the force generator to the patient's chest to facilitate airway clearance; and at least one force connection line. The at least one force connection line may include a first end and a second end opposite to the first end, the first end being configured to connect to the chest engagement device and the second end being configured to connect to the force generator. The at least one force connection line may include a connector system for selectively securing the first end and the second end to the force generator.

[0014] In some embodiments, the connector system may include a connector terminal fixed to one of a force generator and at least one force connection line. The connector terminal may include a connector base having a flow path defined therethrough and at least one engagement tab extending radially from the connector base. The at least one engagement tab may form an elastic member positioned between an extended position outward from the connector base and a retracted position closer to the connector base than the extended position.

[0015] In some embodiments, at least one engagement tab may include a locking body and at least one locking tab that protrudes radially from the locking body for fastening with another of a force generator and at least one force connection line. The locking body may extend cantilevered from the fulcrum to connect to the connector base.

[0016] In some embodiments, the locking body may be connected to a fulcrum at one end. A locking tab may be arranged near a free end of the locking body opposite to that end. The locking body may define an engagement portion disposed between the one end and the free end for engagement with a user's hand to operate the engagement tab between an extended and retracted position.

[0017] In some embodiments, the locking body may be connected to a fulcrum at one end. The locking body may define a free end opposite to that end. A locking tab may be disposed between the one end and the free end. In some embodiments, an engagement portion may be defined near the free end to engage with a user's hand to operate the engagement tab between an extended position and a retracted position.

[0018] In some embodiments, the connector system may include a connector receiving portion fixed to another of a force generator and at least one force connection line. The connector receiving portion may be arranged to selectively receive connector terminals to transmit impact forces from the force generator.

[0019] In some embodiments, the connector receiving portion may include: a flow path for communicating with a flow path of the connector terminal; and a locking receiving portion for accepting selective engagement with at least one engagement tab to selectively secure the connector terminal and the connector receiving portion together.

[0020] The latching receiving portion may be arranged radially outward along the flow path. The flow path of the connector receiving portion may be at least partially defined by the receiving portion base, which is configured to engage with the connector base to provide communication of the flow path.

[0021] In some embodiments, the locking receiver may be arranged to receive at least one engaging tab therein. The receiver base may engage with the connector base. One of the connector receiver and the connector terminal may include a fastener for selectively engaging at least one locking tab of the other to prevent disengagement between the receiver base and the connector base.

[0022] In some embodiments, the connector receiving portion may include a fastener. The connector terminal may include at least one locking tab.

[0023] In some embodiments, the connector system may include a connector terminal fixed to one of at least one force connection wire and one of a force generator. The connector system may also include a connector receiving portion fixed to the other of the force connection wire and the force generator. One of the connector terminal and the connector receiving portion may include a receiving portion base formed as a convex engagement member to be received into a concave engagement member of the other of the connector terminal and the connector receiving portion to provide a flow path connection between the connector terminal and the connector receiving portion. The convex engagement member may be tapered.

[0024] In some embodiments, the convex engagement member is configured to selectively expand in response to a threshold pressure from a force generator in the flow path connection to form a press-fit with the concave engagement member. At least one of the connector terminal and the connector receiver may include at least one magnet. At least the other of the connector terminal and the connector receiver may include at least one magnetic member having a magnetic susceptibility to prevent disengagement between the connector terminal and the connector receiver.

[0025] In some embodiments, at least one magnet may be an electromagnet. At least one magnet may be a permanent magnet. At least one magnetic member may be arranged near the mating surface of at least one of the connector terminal and the connector receiving portion. In some embodiments, at least one magnet may be arranged near the mating surface of at least one of the connector terminal and the connector receiving portion.

[0026] In some embodiments, at least one magnet may be arranged close to the engagement surface. At least one magnet may include a ferromagnetic ring disposed on one side of the radial wall of the magnet. In some embodiments, the chest engagement device may include wearable clothing.

[0027] According to another aspect of this disclosure, a chest wall concussion therapy force generator for generating continuous impact force as a treatment protocol for patients to promote airway clearance may include: a piston pump unit comprising at least two pistons, each deployed in a corresponding piston well, each piston arranged to reciprocate about the corresponding piston well to generate pressure for chest wall concussion therapy according to the treatment protocol; a drive shaft arranged to be connected to a drive motor to provide reciprocating drive for the at least two pistons; and

[0028] A drive linkage mechanism is operably connected to each of at least two pistons and a drive shaft to convert the rotational drive of the drive shaft into the reciprocating motion of the pistons.

[0029] In some embodiments, the drive linkage mechanism may include at least one cam member coupled between a drive shaft and each of at least two pistons to convert rotational drive of the drive shaft into reciprocating motion of the pistons. The at least one cam member may be eccentrically arranged relative to the drive shaft.

[0030] In some embodiments, the drive linkage mechanism may include a link support. The link support may be pivotally coupled to a corresponding piston at one end. The link support may define a cylindrical yoke at the other end for receiving at least one cam member. Eccentric rotation of the at least one cam member within the cylindrical yoke can drive one end of the link support to reciprocate in order to transmit motion to the corresponding piston.

[0031] In some embodiments, the drive linkage mechanism may include a plurality of radial links. Each radial link may be fixed at one end to a drive shaft to receive rotational drive. Each radial link may be coupled at its opposite end to a corresponding piston. Each radial link may include at least one cam member disposed at its opposite end.

[0032] In some embodiments, each piston may include a yoke rail. Each yoke rail may have a length defined perpendicular to the direction of piston reciprocating motion. Each yoke rail may be adapted to receive at least one corresponding cam member for traveling along the length of the yoke rail to convert the rotational motion of the drive linkage into the reciprocating motion of the corresponding piston.

[0033] In some embodiments, each radial link may include a support section. The radial links may extend in opposite directions from their connection to the drive shaft.

[0034] In some embodiments, the generator may include a drive motor, including a stepper motor. The drive motor may be configured to drive a drive shaft to rotate in a first rotational direction and a second rotational direction opposite to the first rotational direction.

[0035] In some embodiments, the treatment control system may be configured to control the operation of the force generator. The treatment control system may be adapted to receive indications of the patient's chest respiratory movements and determine the patient's breathing pattern. The treatment control system may be adapted to configure treatment protocols based on the breathing pattern.

[0036] In some embodiments, the treatment control system may configure the treatment protocol to increase at least one of the force oscillation rate and intensity during the patient's exhalation. Increasing the force oscillation rate and intensity during the patient's exhalation includes increasing at least one of the force oscillation rate and intensity from a first value to a second value greater than the first value during the period of the patient's exhalation. The period of the patient's exhalation may be determined based on the breathing pattern.

[0037] In some embodiments, after the end of the time period, the treatment control system may configure the treatment protocol to reduce at least one of the force oscillation rate and intensity during another time period. This other time period may include the patient's inhalation time. The treatment control system may configure the treatment protocol to reduce at least one of the force oscillation rate and intensity during the patient's inhalation.

[0038] In some embodiments, reducing at least one of the force oscillation rate and intensity during the patient's inhalation may include reducing at least one of the force oscillation rate and intensity from a first value to a second value less than the first value during the period of the patient's inhalation. The period of the patient's inhalation may be determined based on the breathing pattern. After the end of this period, the treatment control system may configure the treatment protocol to increase at least one of the force oscillation rate and intensity during another period. In some embodiments, this second period may include the patient's exhalation time.

[0039] According to another aspect of this disclosure, a chest wall concussion therapy system may include: a chest engagement device for delivering impact force to a patient's chest as a treatment protocol to facilitate airway clearance; a pump unit for generating pressure for the chest engagement device to provide impact force, the pump unit including at least one pressurization group including at least one positive pressure port for providing positive pressure and at least one negative pressure port for providing negative pressure; and a pressure control assembly connected to the pump unit to deliver pressure to the chest engagement device. The pressure control assembly may include: a housing defining a first flow path and a second flow path; and a control body assembly including a first body disposed within the first flow path to regulate fluid flow through the first flow path and a second body disposed within the second flow path to regulate fluid flow through the second flow path. The first flow path may have a pump side connected to the positive pressure port of the pump unit. The second flow path may have a pump side connected to the negative pressure port of the pump unit. Each of the first and second bodies may be selectively operable between an open-flow position and a closed-flow position.

[0040] In some embodiments, the control body may include a flow channel adapted to be selectively arranged to communicate with a corresponding flow path in an open-flow position to allow pressure transmission through the corresponding flow path, and adapted to be selectively arranged not to communicate with a corresponding flow path in the closed-flow position to prevent pressure transmission through the corresponding flow path. Both the first and second control bodies may include at least two angular positions encompassing the open-flow position. The open-flow position of each of the first and second control bodies may include arranging the flow channel to communicate with the corresponding flow path to allow pressure to be transmitted from one end of the flow channel through the corresponding flow path to the other end of the flow channel.

[0041] In some embodiments, the open-flow position of each of the first and second control bodies may include arranging a flow channel in communication with a corresponding flow path to allow pressure to be transferred from one end of the flow channel to one end of the flow channel via the corresponding flow path. Each of the first and second control bodies may be adapted to rotate within its corresponding flow path to alternate between an open-flow position and a closed-flow position. Both the first and second control bodies may include rotation within their respective flow paths such that only one of the first and second control bodies is arranged to be in an open-flow position at all times.

[0042] In some embodiments, the first control body and the second control body may be arranged such that the flow channels of the first control body and the flow channels of the second control body are perpendicular to each other during rotation. Both the first control body and the second control body may be spherical. Both the first control body and the second control body may be oblate.

[0043] In some embodiments, the flow channel of each of the first and second control bodies may extend longitudinally through the control body. In some embodiments, the first and second control bodies may be connected to a drive shaft to rotate within their respective flow paths. The drive shaft is driven to rotate by a drive motor, which is controlled and operated by a treatment control system. In some embodiments, the chest fitting device may include wearable clothing.

[0044] According to another aspect of this disclosure, a chest wall concussion therapy system may include: a chest engagement device for transmitting impact force to a patient's chest; a force generator arranged to generate continuous impact force as a treatment protocol for the patient, the force generator being arranged in communication with the chest engagement device to transmit the impact force from the force generator to the patient's chest to facilitate airway clearance; and a treatment control system. The treatment control system may include a graphical user interface for communicating with a user.

[0045] In some embodiments, the graphical user interface may be arranged to present optional options. Optional options may include a treatment start button for initiating an operation to deliver an impact force to the patient. In response to the user activating the treatment start button, the graphical user interface may present a pause button as an optional option.

[0046] In some embodiments, optional options may include a pull-out tab that can be activated by the user to present additional optional options. Additional optional options may include at least one of a home button, a cough pause settings button, and a delete treatment button. Optional options may include a new scheduled treatment button that allows the user to create a new scheduled treatment plan to be implemented as a treatment plan. The new scheduled treatment button can be accessed by the user activating a pull-out tab to expand it.

[0047] In some embodiments, optional options may include an unlock button. In response to user activation of the unlock button, at least one of a frequency button, an intensity button, and a time button may be presented as optional options for user activation to configure the corresponding feature. User activation of the unlock button may include dragging the unlock button to a predetermined area. Optional options may include a predetermined treatment plan tab for implementing a predetermined treatment plan as a treatment plan.

[0048] In some embodiments, in response to the user activating at least one of the Pre-defined Treatment Plan tab and the Unlock button, a Cough Pause tab may be presented for the user to activate in order to configure the cough pause settings of the pre-defined treatment plan. In response to the user activating the Cough Pause tab, at least one of a Cough Pause Enable switch and an Auto Restart switch may be presented for the user to select. In response to the user activating the Cough Pause Enable switch to confirm cough pause, at least one of a Pause Duration button and a Pause Frequency Interval button may be presented for the user to activate in order to adjust the relevant features.

[0049] In some embodiments, the chest fitting device may include wearable clothing. In some embodiments, the treatment control system may include a clothing size switching switch. The clothing size switching switch is operable to allow a user to select between an on position and an off position, wherein in the on position, the treatment control system adjusts the configuration of the force generator to take into account the size of the wearable clothing, and in the off position, the treatment control system does not adjust the configuration of the force generator to take into account the size of the wearable clothing.

[0050] Additional features (including those listed above and those listed in the claims) may individually or in combination with any other features encompass patentable subject matter, and these additional features will become apparent to those skilled in the art in light of the following detailed description of illustrative embodiments to illustrate what is now considered the best mode of implementation of the invention. Attached Figure Description

[0051] In particular, a detailed explanation is provided in conjunction with the accompanying diagram, which shows:

[0052] Figure 1 This is a perspective view of a high-frequency chest wall vibration system, which includes a chest engagement device (vest) and a force generator.

[0053] Figure 2 for Figure 1 A close-up perspective view of the breast-jointing device;

[0054] Figure 3 This is a schematic view of a sensor that can be attached to a chest fitting device to transmit motion and / or position information of the patient's chest.

[0055] Figure 4 According to Figure 3 A diagram showing how the respiratory pattern is determined using sensor data from the sensor in the middle;

[0056] Figure 5 For indication Figure 1 A flowchart illustrating the operation of the treatment and control system in the middle stage;

[0057] Figure 6 for Figure 1 A perspective view of the force generator, showing the graphical user interface for user communication and the connector system for connecting the hose;

[0058] Figure 7 for Figure 6 A perspective view of an embodiment of a connector system;

[0059] Figure 8 for Figure 7 Cross-sectional view of the connector system;

[0060] Figure 9 for Figure 6A perspective view of another embodiment of the connector system;

[0061] Figure 10 for Figure 9 Cross-sectional view of the connector system;

[0062] Figure 11 for Figure 6 A perspective view of another embodiment of the connector system;

[0063] Figure 12 for Figure 11 A cross-sectional view of the connector system;

[0064] Figure 13 for Figure 6 A cross-sectional view of another embodiment of the connector system;

[0065] Figure 14 for Figure 13 Perspective view of the connector system;

[0066] Figure 15 for Figure 6 A perspective view of another embodiment of the connector system;

[0067] Figure 16 for Figure 15 Another perspective view of the connector receiving part of the connector system;

[0068] Figure 17 for Figure 15 Cross-sectional view of the connector system;

[0069] Figure 18 for Figure 6 A cross-sectional view of another embodiment of the connector system;

[0070] Figure 19 for Figure 1 Front view of the medium force generator;

[0071] Figures 20 to 41 for Figure 18 The GUI of the force generator displays a screen indicating various operations of the force generator;

[0072] Figures 42 to 44 Perspective views of various embodiments of the housing of a force generator, the housing of which includes a handle for handling;

[0073] Figure 45 for Figure 1 Plan view of the pump unit of the medium force generator;

[0074] Figure 46 for Figure 45 Cross-sectional view of the intermediate pump unit;

[0075] Figure 47 for Figure 45 Another cross-sectional view of the intermediate pump unit;

[0076] Figure 48 for Figure 1 Perspective view of another embodiment of the pump unit portion of the medium-force generator;

[0077] Figure 49 for Figure 1 A front view of another embodiment of the pump unit section of the medium-force generator;

[0078] Figure 50 for Figure 49 Cross-sectional view of the pump control components of the medium-sized pump unit;

[0079] Figures 51 to 78 for Figure 18 The GUI of the force generator displays additional screens indicating various operations of the force generator. Detailed Implementation

[0080] To facilitate understanding of the principles of this disclosure, several illustrative embodiments will now be described with reference to the accompanying drawings and using specialized language.

[0081] Promoting expectoration can effectively treat buildup in the upper respiratory tract, such as mucus buildup in patients with cystic fibrosis. High-frequency chest wall oscillation (HFCWO) can help dissolve this buildup.

[0082] Now refer to Figure 1 The diagram illustrates a chest wall treatment system 12 comprising a chest engagement device 14, embodied as a wearable vest; and a therapeutic force generator 16, connected to the vest 14 via a pair of hoses 18, 20, to provide impact force delivered by the vest 14 to the patient's torso area to apply impact force to the chest wall. Continuous application of impact force to apply high-frequency vibrations to the chest wall as a treatment regimen can help expel mucus from the upper respiratory tract.

[0083] The force generator 16 is illustratively represented as including an air pump unit adapted to provide positive and negative pressure to the vest 14 via corresponding hoses 18, 20. In some embodiments, such an arrangement may, for example, include only one or more positive pressure hoses to provide positive pressure, while pressurized fluid may be discharged without returning to the force generator. (Refer to...) Figure 2 The vest 14 includes a plurality of pressurizable chambers 22 (shown in dashed lines) defined within the garment. The pressurizable chambers 22 are arranged to communicate with hoses 18, 20 to receive continuous pressurization and depressurization for continuous inflation and deflation, thereby applying a shock force to the patient.

[0084] Vest 14 includes sensor 24 arranged to detect chest wall movement in a patient to determine a breathing pattern. Sensor 24 is fixed to vest 14 and is illustratively located inside the garment. Sensor 24 is illustratively positioned near the sternal portion of vest 14, but in some embodiments, sensor 24 may have any suitable arrangement to facilitate the determination of breathing information.

[0085] Reference Figure 3 Sensor 24 includes multiple sensor features 26. Sensor features 26 are illustratively represented as microelectromechanical sensors, including three accelerometers 28, three gyroscopes 30, and three magnetometers 32. Sensor 24 is arranged to communicate with force generator 16 to provide sensor data as an indication of patient breathing. In an illustrative embodiment, sensor features 26 transmit indications of their respective detected motion activities to force generator 16. Force generator 16 includes processor 34, memory 36 storing instructions executed by processor 34, and communication circuitry 38 arranged to transmit signals according to instructions from processor 34, including sending and receiving signals. Processor 34, memory 36, and circuitry 38 constitute a treatment control system 46 for controlling the operation of force generator 16 to provide pressure as an impact force for delivery to vest 14. In some embodiments, sensor 24 may be included within the treatment control system.

[0086] In an illustrative embodiment, sensor 24 is hardwired to force generator 16 to transmit indications of patient respiratory activity. In some embodiments, sensor 24 may communicate wirelessly with the force generator, such as via Bluetooth, WiFi, and / or other suitable local wireless communication, and may include processor 40, memory 42 for storing instructions executed by the processor, and communication circuitry 44 for transmitting signals according to instructions from processor 40. In some embodiments, sensor 24 and / or force generator 16 may transmit sensor data and / or force generator operation information directly and / or indirectly to a user's personal mobile device 48 via a wireless connection (such as via Bluetooth, WiFi, and / or other suitable local wireless communication).

[0087] The treatment control system 46 controls the pressure generation of the force generator 16. In an illustrative embodiment, the treatment control system 46 controls the initiation and termination of treatment, the pressure and / or flow rate of the provided positive and negative pressures, and the oscillation frequency between the provided positive and negative pressures. As detailed herein, the treatment control system 46 includes a user interface for communicating with a user.

[0088] Reference Figure 4The treatment control system 46 illustratively determines the patient's breathing pattern based on sensor data. The treatment control system 46 illustratively determines the patient's breathing pattern by calculating and analyzing the sensor data to provide the motion structure of the patient's breathing. In an illustrative embodiment, the motion structure includes a three-dimensional motion structure. Based on the motion structure, the treatment control system 46 can configure a treatment plan.

[0089] like Figure 4 As shown, the treatment control system 46 can determine when the patient inhales and / or exhales based on the breathing pattern. By configuring the treatment plan according to the timing of the patient's inhalation and / or exhalation, the effectiveness and / or comfort of the treatment can be improved. For example, preferred treatment results can be obtained by providing an ideal high intensity and / or oscillation frequency during exhalation. However, during inhalation, the effectiveness of HFCWO decreases and / or the patient experiences discomfort. Therefore, patient comfort can be enhanced by applying a lower intensity and / or oscillation frequency during inhalation, while maintaining treatment effectiveness by applying an increased intensity and / or oscillation frequency during exhalation.

[0090] Now refer to Figure 5 The diagram illustrates the operation of the treatment control system 46 configuring a treatment plan. The initial treatment plan may include predetermined settings for the intensity, frequency, and / or duration of HFCWO treatment. During treatment, in box 50, the treatment control system 46 may detect the patient's breathing pattern. Sensor 24 illustratively senses the motion exerted by the patient's breathing and transmits sensor data to determine the breathing pattern.

[0091] In box 52, the treatment control system 46 can determine the breathing pattern and can determine the configuration of the treatment plan based on the breathing pattern. In box 54, the treatment control system 46 can execute the configured treatment plan according to the breathing pattern. Executing the configured treatment plan may include adjusting one or more of the intensity, frequency, and duration of the oscillation therapy.

[0092] The treatment control system 46 may optionally consider adverse respiratory factors. Sensor data from sensor 24 may be analyzed by the treatment control system 46 to identify risk factors for respiratory problems. For example, in box 52, the treatment control system 46 may determine respiratory rate and / or tidal volume based on sensor data and may determine the existence of a risk related to the ventilator affecting the patient's lung function. In box 56, in response to determining the existence of a risk, the treatment control system 56 may issue a warning. Issuing a warning may include activating a warning light, displaying a warning message on the user interface, and / or transmitting a warning indication to a remote system.

[0093] Now refer to Figure 6The force generator 16 illustratively includes a user interface, which is embodied as a graphical user interface (GUI) 58. The GUI 58 is embodied as a touch screen display that can be used to display graphical images, including user interaction buttons that can be selected by the user to provide user input.

[0094] like Figure 6 As shown, the force generator 16 includes a pressurization assembly 60, which includes a positive pressure port 62 and a negative pressure port 64 for transmitting impact force to the vest 14. The positive pressure port 62 is arranged to receive a connecting hose 18, and the negative pressure port 64 is arranged to receive a connecting hose 20. The hoses 18 and 20 are connected to the corresponding ports 62 and 64 as a connector system 66, which allows selective connection of the hoses 18 and 20 to the ports 62 and 64.

[0095] Now refer to Figure 7 The connector system 66 is shown in more detail below. The connector system 66 includes a connector terminal 68 fixed to hoses 18, 20 as an end connector. The connector system 66 also includes a connector receiving portion 70 fixed to a force generator 16 as an end terminal of ports 62, 64. The connector terminal 68 and the connector receiving portion 70 are configured to engage in a coordinated manner to allow pressure to be transmitted between the force generator 16 and the vest 14 via hoses 18, 20. In this illustrative disclosure, the connector terminal 68 is fixed to hoses 18, 20 and the connector receiving portion 70 is fixed to the force generator 16; however, in some embodiments, the connector receiving portion 70 may be fixed to hoses 18, 20 and the connector terminal 68 may be fixed to the force generator 16.

[0096] Connector terminal 68 includes a connector base 74 having a flow path 76 defined therethrough. Connector terminal 68 includes an engagement tab 77 extending radially from connector base 74. Connector base 74 is illustratively configured as a tubular member for coordinated engagement with connector receiving portion 70 to provide a pressurized flow connection. Engagement tab 77 is illustratively configured as a resilient member positionable between an extended position and a retracted position, in which the connector terminal 68 is locked to connector receiving portion 70 to prevent disengagement, and in the retracted position, the lock between connector terminal 68 and connector receiving portion 70 is released.

[0097] Still refer to Figure 7 The connector receiving portion 70 includes a receiving base 78 that defines a flow path 80 therethrough. The receiving base 78 is configured to engage with a connector base 74 to provide a pressurized flow connection. The connector receiving portion 70 includes a locking receiving portion 82 configured to selectively receive a connector terminal 68 to transmit impact force.

[0098] Now refer to Figure 8Connector terminal 68 is received within connector receiving portion 70. Connector base 74 engages with receiving portion base 78 to provide communication between flow paths 76, 80. Engaging tab 77 is received within locking receiving portion 82 and is shown arranged in an extended position that locks connector terminal 68 to connector receiving portion 70.

[0099] Each of the engagement tabs 77 is formed to include a locking body 84, which is embodied as an elongated member. The locking body 84 is connected to the connector base 74 at a fulcrum 86 and extends cantileveredly from the fulcrum 86 to a free end 88. Each locking body 84 includes an outwardly extending locking tab 90 for selective engagement with the locking reception portion 82 of the connector reception portion 70.

[0100] Each locking body 84 includes an engagement portion 92 for engaging with a user's hand to selectively operate the engagement tab 77 between an extended and retracted position. The engagement portion is illustratively represented as a plurality of teeth projecting from the locking body 84 to improve the gripping surface for engagement with the user's hand. The user can engage the engagement portion to apply and release an inward force F on the locking body, causing the locking body 84 to pivot about a fulcrum 86 to the retracted position, disengaging the locking tab from the locking receiver 82, thereby allowing disengagement between the connector terminal 68 and the connector receiver 70.

[0101] Each latching receiver 82 includes a latching opening 94 for receiving engagement of the latching tab 90 when the corresponding engagement tab 77 is in the extended position, thereby preventing disengagement between the connector terminal 68 and the connector receiver 70. The user can press the engagement tab 77 into the retracted position to disengage the latching tab 90 from the latching opening 94, thereby allowing the connector terminal 68 to disengage from the connector receiver 70.

[0102] like Figure 9 and Figure 10 As shown, another embodiment of connector system 1066 is illustrated, similar to connector system 66. The disclosure of connector system 66 also applies to connector system 1066, unless it contradicts the specific disclosure of connector system 1066. Connector system 1066 includes connector terminal 1068 and connector receiving portion 1070, which are adapted to coordinately engage to communicate pressurized flow. In the illustrative embodiment, connector terminal 1068 is secured to hoses 18, 20 and connector receiving portion 1070 is secured to ports 62, 64 of force generator 16; however, in some embodiments, either connector terminal 1068 or connector receiving portion 1070 may be secured to hoses 18, 20 while the other connector terminal 1068 or connector receiving portion 1070 may be secured to a corresponding port 62, 64.

[0103] Connector terminal 1068 includes connector base 1074 defining flow path 76 and receiving base 1078 defining flow path 80. Connector base 1074 and receiving base 1078 are configured to engage in a coordinated manner to communicate their flow paths 76, 80. Connector terminal 1068 includes engagement tab 1077 for selective engagement with locking receiving portion 1082 of connector receiving portion 1070 to prevent disengagement of connector terminal 1068 from connector receiving portion 1070.

[0104] Each engagement tab 1077 includes a locking body 1084, one end of which is connected to the connector base 1074 via a fulcrum 1086. Each locking body 1084 extends from the corresponding fulcrum 1086 to a free end 1088. Each engagement tab 1077 includes a locking tab 1090 configured to selectively engage with a locking opening 1094 of a locking receiving portion 1082 to prevent disengagement of the connector terminal 1068 from the connector receiving portion 1070.

[0105] Unlike connector system 66, locking tab 1090 is arranged on locking body 1084 near free end 1088, and free end 1088 is received within locking receiver 1082 during engagement of connector terminal 1068 and connector receiver 1070. Also unlike connector system 66, locking receiver 1082 is formed as a uniform annular member.

[0106] The engagement tab 1077 includes an engagement portion 1092 for engaging with a user's hand to operate the engagement tab 1077 between an extended position and a retracted position. In the extended position, as... Figure 10 As shown, the locking tab 1090 engages with the locking opening 1094 of the locking receiver 1080 to prevent the connector terminal 1068 from disengaging from the connector receiver 1070. When the user presses the engagement tab 1077 into the retracted position, the locking tab 1090 disengages from the locking opening, thereby allowing the connector terminal 1068 to disengage from the connector receiver 1070.

[0107] Now refer to Figures 11 to 14Another connector system 2066 is shown. The disclosures of connector systems 66 and 1066 also apply to connector system 2066, unless they contradict the specific disclosure of connector system 2066. Connector system 2066 includes connector terminal 2068 and connector receiver 2070, which are arranged to engage in a coordinated manner to connect their flow paths 76 and 80. In the illustrative embodiment, connector terminal 2068 is fixed to hoses 18 and 20 and connector receiver 2070 is fixed to ports 62 and 64 of force generator 16, but in some embodiments, either connector terminal 2068 or connector receiver 2070 may be fixed to hoses 18 and 20 while the other connector terminal 2068 or connector receiver 2070 may be fixed to a corresponding port 62 or 64.

[0108] Connector terminal 2068 includes connector base 2074 defining flow path 76. Connector terminal 2070 includes connector base 2078 defining flow path 80. Connector base 2074 and receiving base 2078 are arranged to engage in a coordinated manner to communicate their flow paths 76, 80. Connector terminal 2068 includes engagement flange 2112 for engaging with engagement flange 2114 of connector receiving portion 2070.

[0109] The mating flange 2112 of the connector terminal 2068 illustratively protrudes from the connector base 2074 to define a mating surface 2116. The mating surface 2116 of the connector terminal 2068 includes a magnetizable member 2118 with high magnetic susceptibility, which, when placed in a magnetic field, is high enough to selectively form a magnetic connection to prevent the connector terminal 2068 from disengaging. The magnetizable member 2118 is illustratively formed as an annular member of an ferrous material to be attracted by a magnet; however, in some embodiments, the magnetizable member 2118 may include any suitable shape and / or material to allow selective engagement with the connector receiving portion 2070.

[0110] The engagement flange of the connector receiving portion 2070 extends from the receiving portion base 2078. The engagement flange 2114 defines an engagement surface 2120 for selective engagement with the engagement surface 2116 of the connector terminal 2068. The engagement surface 2120 of the connector receiving portion 2070 includes a magnetic member 2122 for attractive connection with the engagement surface 2116 of the connector terminal 2068. The magnetic member 2122 illustratively includes a permanent magnet with a magnetic field sufficient to selectively hold the connector terminal 2068 to the connector receiving portion 2070.

[0111] When the connector terminal 2068 and the connector receiving portion 2070 are arranged sufficiently close together to magnetize the magnetizable member 2118 under the magnetic field of the magnetic member 2122, the connector terminal 2068 and the connector receiving portion 2070 can be magnetically attracted together to prevent the connector base 2074 from disengaging from the receiving portion base 2078. Accordingly, the mating flanges 2112 and 2114 together define the magnetic coupling for selective connection between the connector terminal 2068 and the connector receiving portion 2070. In the illustrative embodiment, the connector terminal 2068 includes the magnetizable member 2118 and the connector receiving portion 2070 includes the magnetic member 2122; however, in some embodiments, the connector terminal 2068 includes the magnetic member 2122 and the connector receiving portion 2070 may include the magnetizable member 2118.

[0112] By arranging the mating flanges 2112 and 2114 adjacently to apply magnetic attraction and allowing the magnetic attraction to freely draw the mating surfaces together, the magnetic coupling is illustratively adapted to produce an audible click and / or tactile magnetic attraction during mating. The user can perceive the connection between the connector terminal 2068 and the connector receiver 2070 through auditory and / or tactile feedback.

[0113] Now refer to Figure 12 The diagram illustrates a connector system 2066, wherein a connector base 2074a is formed with a tapered thickness extending away from the mating surface 2116 to facilitate engagement between the connector base 2074a and a receiving base 2078a. The receiving base 2078a is shown having an elongated section to engage the connector base 2074a. The mating flange 2114 is shown including a radially outwardly extending receiving extension 2124.

[0114] Now refer to Figures 15 to 17 Another connector system 3066 is shown. The disclosures of connector systems 66, 1066, and 2066 also apply to connector system 3066, unless they contradict the specific disclosure of connector system 3066. Connector system 3066 includes connector terminals 3068 and connector receivers 3070, which are arranged to engage in a coordinated manner to connect their flow paths 76, 80. In the illustrative embodiment, connector terminal 2068 is fixed to hoses 18, 20 and connector receiver 3070 is fixed to ports 62, 64 of force generator 16; however, in some embodiments, either connector terminal 3068 or connector receiver 3070 may be fixed to hoses 18, 20 and the other may be fixed to a corresponding port 62, 64.

[0115] Similar to connector system 2066, connector system 3066 is shown to include magnetic coupling for selectively coupling connector terminal 3068 to connector receiver 3070. However, unlike connector system 2066, connector receiver 3070 of connector system 3066 is formed to include electromagnet 3126 for selectively applying a magnetic field to attract connector terminal 3068. Electromagnet 3126 is illustratively activated in response to activation of a treatment protocol to prevent disengagement between connector terminal 3068 and connector receiver 3070 during the treatment protocol. In some embodiments, the magnetic force of the electromagnet may accumulate to a permanent magnet arranged to easily maintain coupling between connector terminal 3068 and connector receiver 3070 when the treatment protocol is not currently running.

[0116] Electromagnetic element 3126 is illustratively arranged on the rear side of receiving extension 3124, extending circumferentially around receiving base 3078. Connector receiving portion 3070 includes magnetizing member 3128, which is arranged within engagement flange 3114 on the opposite side of receiving extension 3124, adjacent to electromagnetic element 3126 to become magnetized under the operation of electromagnetic element 3126. Magnetizing member 3118 has high magnetic susceptibility to become magnetized under the magnetic field of electromagnetic element 3126, thereby magnetically coupling with magnetizing member 3118 of connector terminal 3068 when arranged adjacent to each other.

[0117] Now refer to Figure 18 Another connector system 4066 is shown. The disclosures of connector systems 66, 1066, 2066, and 3066 also apply to connector system 4066, unless they contradict the specific disclosure of connector system 4066. Connector system 4066 is shown as including connector terminal 4068 and connector receiving portion 4070, which engage with each other to communicate their flow paths 76, 80. Connector terminal 4068 includes connector base 4074, which extends to engage with receiving base 4078 of connector receiving portion 4070. In the illustrative embodiment, connector base 4074 extends into receiving base 4078 such that outer surface 4130 of connector base 4074 engages inner surface 4132 of receiving base 4078.

[0118] The connector base 4074 and the receiving base 4078 are illustratively configured to cooperate so that, when the force generator 16 is not operating to provide pressure, the connector terminal 4068 and the connector receiving portion 4070 are easily coupled together by frictional engagement. When the force generator 16 operates to pressurize the flow paths 76, 80, the connector terminal 4068 and the connector receiving portion 4070 are coupled together more tightly to apply a stronger frictional engagement. In the illustrative embodiment, under baseline pressure, the connector base 4074 of the connector terminal 4068 expands slightly, such that the circumference of the outer surface 4130 is slightly larger than the circumference when no pressure is provided. Accordingly, during the operation of the force generator 16 to provide a treatment, disengagement between the connector terminal 4068 and the connector receiving portion 3079 can be selectively prevented.

[0119] Now refer to Figure 19 The force generator 19 is shown to include a graphical user interface (GUI) 58. The GUI 58 illustratively presents an introduction screen 212, identifying the product name, supplier, and / or graphic design elements. The introduction screen 212 illustratively includes an indication of the total treatment hours (214), indicating the total number of hours of operation for which treatment has been provided. The introduction screen 212 includes an indication of the available software version 216 on the force generator 16, currently indicating version 1.0.

[0120] like Figure 20 As shown, in response to a timeout on introductory screen 212, GUI 58 proceeds to screen 214. On screen 214, GUI 58 presents multiple tab options, including tabs 220, 222, and 224, as indicated by the continuous connection of tab 220 to the rest of screen 214 (the right-hand portion). Tab 220 is currently selected. The currently selected tab 220 presents multiple selection button options, including a treatment start button 226 and settings option buttons 228, 230, and 232.

[0121] Buttons 228, 230, and 232 are currently unavailable for selection (they are locked, as detailed herein) and can be grayed out to indicate unavailable. Buttons 228, 230, and 232 indicate their currently selected setting values, such as the frequency, intensity, and duration of treatment conditions as part of a treatment regimen. The currently selected HFCWO treatment setting value is illustratively applied as the default setting for the currently selected treatment regimen, and in the HFCWO system's dynamic determination of the setting value arrangement during treatment, for example, based on the determination of the user's breathing as described above, dynamic changes in the setting are determined to decrease the frequency and / or intensity value during inspiration and / or increase the frequency and / or intensity value during expiration. The currently selected setting value is represented as a maximum setting, which can be affected by dynamically lowering the setting from these maximum settings; however, in some embodiments, the currently selected setting value may be an average or minimum value, which can be dynamically adjusted upwards and / or downwards based on the determination of the control system. The setting value may be directly associated with an identified unit, such as a duration value represented in minutes, but in some embodiments may have any suitable unit, including non-standard units and / or weighted units. On screen 214, buttons 228, 230, and 232 are indicated as currently unselectable (grayed out, as shown by their dark background and white text). Setting button 225 is displayed but indicated as currently unselectable (grayed out, as shown by its non-bold depiction).

[0122] The GUI 58 presents a title bar 234 visible across several screens. The title bar 234 illustratively includes a supplier icon 236, a system lock button 238 indicating the current lock arrangement via a graphical representation of a closed padlock, and a wireless communication indicator 240. The wireless communication indicator 240 illustratively includes a WiFi indicator 242 and a Bluetooth indicator 244, both used to indicate the availability of their respective connection types.

[0123] The user selects the treatment start button 226 from screen 214 to activate the force generator 16 to provide the currently set treatment conditions as the treatment plan, and advances GUI 58 to... Figure 21 Screen 248 is shown. On screen 248, timer 250 indicates the duration of the currently provided treatment, represented by a numerical and graphical indicator (2 minutes 0 seconds and a semicircle of bars indicating 2 minutes out of 10 minutes). In response to starting treatment, treatment start button 226 is replaced by treatment pause button 252. Since the currently set treatment duration is ten minutes after the end of the ten-minute treatment run (as shown by button 232), an indication that treatment is complete is responsively presented on GUI 58. In the illustrative embodiment, the indication that treatment is complete includes a message on GUI 58. In response to message timeout and / or user tap anywhere on GUI 58, GUI 58 returns to screen 214.

[0124] In response to the user selecting the treatment pause button 252, the oscillation treatment is paused by stopping the pressure oscillation from the force generator 16, and the GUI 58 proceeds to... Figure 22 Screen 254 is shown. On screen 254, the treatment start button 226 replaces the treatment pause button 252, and a return button 251 is presented to allow returning to the previous screen. The pause timer 256 is presented as an indication of the actual time elapsed from the predetermined maximum pause time of 8 minutes, represented by digital and graphical indicators (4 minutes and 15 seconds and a semicircle composed of bars indicating 4 minutes and 15 seconds out of the 8 minutes).

[0125] In the illustrative embodiment, if the pause timer reaches 6 minutes, a warning indication is displayed indicating that treatment will terminate if it is not restarted. The warning indication includes a countdown timer showing the remaining time before treatment termination and presents "Continue Treatment" and "End Treatment" buttons for the user to choose from. If treatment is not continued (cancelled) within the predetermined maximum time or the user selects the "End Treatment" button, an "Incomplete Treatment" indication is displayed, and in response to the "Incomplete Treatment" indication timeout and / or the user tapping anywhere on GUI 58, the system returns to screen 214. If the user continues (cancelled) treatment by selecting the "Continue Treatment" button within the maximum pause time, treatment continues, and the GUI returns to screen 248.

[0126] Now refer to Figure 23 The user selects the lock button 238 from any of the screens 214, 248, or 254 where the lock button 238 is available to provide an unlocked state, proceeding to screen 258. Selecting the lock button 238 to unlock is indicated by a long press (e.g., pressing for 2 seconds). Screen 258 is similar to screen 214, but this time the lock button 238 indicates that unlocking has been selected via a graphical representation of an unlocked padlock, and the settings button 225 is activated at this time (as shown in bold). If the settings button 225 is unavailable, the user can select the lock button 238 to return to the locked state, and / or return to the locked state in response to a timeout (>30 seconds, no touch).

[0127] In the unlocked state, buttons 228, 230, and 232 are activated for user selection, as indicated by their grayed-out appearance in the locked state. The user selects button 228 to proceed to... Figure 24 The screen 260 is shown. The current selection button 228 is highlighted via the highlight button 228 (in... Figure 24 The color is inverted, and the script above button 228 indicates "Frequency". In response to the user selecting button 228, increase button 262 and decrease button 264 are presented for the user to select to change the current value (11Hz) of the frequency as indicated by button 228 itself. Home button 266 is presented for the user to select to navigate to screen 214.

[0128] Now refer to Figure 25 In response to the user selecting intensity button 230, button 230 is highlighted and a script above button 230 indicates the currently selected intensity. Buttons 262 and 264 are presented for the user to select to change the current value (5 / 10) of the force intensity applied to the patient, as indicated by button 230 itself.

[0129] Now refer to Figure 26 In response to the user selecting duration button 232, button 232 is highlighted and a script above button 232 indicates the currently selected duration. Buttons 262 and 264 are presented for the user to select to change the current value (10 minutes) of the treatment duration as indicated by button 232 itself.

[0130] Select the treatment start button 226 from screen 260 to activate the force generator 16 to provide the currently set treatment conditions as the treatment plan, and advance GUI 58 to... Figure 27 Screen 268 is shown. On screen 268, the treatment pause button 252 replaces the treatment start button 226, and the treatment timer 250 is displayed. When the treatment duration ends, an indication that the treatment is complete and an indication of the amount of time taken to complete the treatment are displayed, after which the user returns to screen 214. As described above regarding screen 254, if the user selects the pause button 252, the pause timer 256 is displayed, the treatment start button 226 replaces the pause button 252, and the pause control operation continues.

[0131] Now refer to Figure 28 As shown by the connection between tab 222 and other optional options on the right side, the user has selected the treatment tab 222. The treatment start button 226 is presented together with the treatment settings buttons, which include the interval button 290, the frequency button 228, the intensity button 230, and the duration button 232. Buttons 290, 228, 230, and 232 are initially unselectable and can be grayed out to indicate to the user that they are not selectable.

[0132] Reference Figure 29 The user selects the treatment start button 226 to activate the force generator 16, providing the currently set treatment conditions as the treatment plan, and advances the GUI 58 to screen 292. On screen 292, buttons 290, 228, 230, and 232 become available, contrasting with their grayed-out appearance when unavailable, which can be indicated by highlighting. Buttons 290, 228, 230, and 232 all indicate their corresponding current values; for example, the interval button 290 currently indicates "1," indicating that the first interval is activated. The treatment interval timer 294 is displayed as a numerical description including the remaining time (24 minutes) for the entire treatment plan and the current interval (1 / 8).

[0133] exist Figure 30 In the settings, the user has activated the unlock to allow adjustment of HFCWO settings during treatment. Frequency button 228 is currently selected, and increase button 296 and decrease button 298 are activated for the user to choose to increase or decrease the frequency of the first step of treatment.

[0134] Reference Figure 31 An example of screen 292 during operation is shown. The interval timer 294 indicates 7 minutes and 1 second remaining in the entire treatment plan via a digital script and five thinner bars, while the remaining three bars (one incomplete bar) are thicker to indicate they still have time left. The interval timer 294 indicates that interval 6 / 8 is currently being executed via a digital script, and the interval button 290 similarly indicates interval 6. Complete execution of the entire treatment plan (including all intervals) responsively presents an indication that the treatment is complete, and returns to screen 214 in response to timeout and / or user touch on any area of ​​the GUI 58.

[0135] The user selects the pause button 252 from screen 292 to pause the vibration therapy and proceeds to screen 298. Figure 32 On screen 298, the treatment start button 226 replaces the pause button 252 and a pause timer 256 is displayed, indicating the pause time (currently accumulated to 5 minutes and 46 seconds). If the pause continues for more than 2 minutes within the predetermined maximum pause time (e.g., 8 minutes), a 2-minute warning is displayed, indicating that the treatment will be canceled if it is not resumed before the predetermined maximum pause time is reached, and a resume button and a stop button are displayed for the user to choose from. The treatment is terminated during the pause, or responsively displayed as the predetermined maximum pause time has expired and / or as the user selects the stop button, indicating that the treatment has been terminated. During the indication that the treatment has been terminated, the user returns to screen 214 in response to a timeout and / or the user touching anywhere on GUI 58. If the user selects the stop button, a termination confirmation is requested by displaying confirmation and cancellation options for the stop button.

[0136] Now refer to Figure 33 From any screen (e.g., screens 214, 292, 298) where the lock button 238 can be selected / activated to unlock settings when the treatment tab 222 is selected, the user can proceed to screen 300 by long-pressing to select / activate the lock button 238 to unlock settings controls. Unlocking settings controls makes settings button 225 available for adjusting preset treatment conditions of the treatment tab 222.

[0137] The user selects the settings button 225 from screen 300 to open the preset treatment condition control interface for selecting the treatment tab 222. Currently, preset treatment one (treatment 1) is indicated. Figure 34As shown on screen 302. On screen 302, a general settings tab 303 and a cough pause settings tab 305 are presented. The general settings tab 303 is as follows: Figure 34 The current selection is shown in the image. With the current selection for the General Settings tab of the selected treatment tab 222 (indicated as Therapy 1), treatment buttons 290, 228, 230, and 232 are presented for selection to adjust their respective preset values.

[0138] On the left-hand side, the currently selected treatment tab 222 is indicated by the script "Therapy 1 (Healing 1)". Figure 34 In the illustrative example, interval button 290 is currently selected, and the indicator for interval 304 is presented on the left side of screen 302, indicating the selection of the first step "1 / 1" of the entire interval via a numerical script and a single circular bar. An add step button 306 and a return-to-previous-step button 308 are presented to allow the user to choose to add an additional step and immediately return to the previous step. Since only one interval step is currently set, the previous step is currently unavailable on screen 302, as indicated by button 308 being grayed out. A delete step button 310 is presented for the user to select to delete the currently selected interval step.

[0139] like Figure 35 As shown, when the user selects the Add Step button 306, this button responsively changes the indication of the interval 304 to indicate, through text script and the depiction of a circular bar, that the currently selected step 2 / 2 has two segments. Selecting the Add Step button changes the interval button 290 to indicate that step 2 is selected by scrolling the depicted dial to value 2, where number 1 is shown above dial number 2 and a horizontal bar is shown below dial number 2 to indicate that only two intervals currently exist. When more than one interval exists and the user navigates to an intermediate step using the Back to Previous Step button 308, the Add Step button 306 is replaced by the Next Step button. Figure 35 In the middle, the user selects the add button 306 to continue adding interval steps in a similar manner.

[0140] The user selects the frequency button 228 of the currently selected interval step from screen 300 to allow the user to adjust the frequency of that interval step, as shown on screen 302. The frequency button 228 is highlighted to indicate that the button is selected, and increase buttons 312 and decrease buttons 314 are presented for the user to select to increase or decrease the frequency of the selected interval step, respectively. The user selects the add step button 306 or the return to previous step button 308 to hold the current selection buttons 228, 230, 232 to allow the user to navigate the settings to adjust the selected conditions. Similarly, the user selects other setting condition buttons 228, 230, 232 to allow increase buttons 312 and decrease buttons 314 to control the currently selected settings (i.e., frequency, intensity, duration) for the currently selected interval step. In an illustrative embodiment, the user can select the lock button 238 to save and complete a preset treatment procedure. In some embodiments, a save button may be presented to save and end a preset treatment procedure.

[0141] Now refer to Figure 37 The user selects the cough pause tab 305 from screen 302 to proceed to screen 316, where a cough pause option 318 is presented for the currently selected interval step. The cough pause option 318 includes: a cough pause enable toggle switch 320 to automatically pause the treatment protocol for the cough interval during the interval step; and an automatic restart toggle switch 322 for automatically restarting (resuming) treatment after a cough pause without user input when enabled, or requiring user input to resume the treatment protocol when disabled.

[0142] Cough pause option 318 includes a cough pause duration setting 324 and a cough pause interval setting 326 for the currently selected interval step. When the cough pause enable toggle switch 320 is disabled (e.g....), Figure 37 As shown), the cough pause duration setting 324 and cough pause interval setting 326 are unavailable and can also be indicated by being grayed out.

[0143] Enabling the cough pause enable toggle switch 320 makes the cough pause duration setting 324 and the cough pause interval setting 326 selectable, such as Figure 38As shown. The user can be instructed to select the cough pause duration setting 324 by highlighting the setting button 324 and indicating the script "Duration" above the setting button 324. In response to selecting the cough pause duration setting 324, increase button 328 and decrease button 330 are presented for the user to select and adjust the value of the current cough duration condition for the currently selected interval step (currently set to 4 minutes). The user can be instructed to select the cough pause interval setting 326 by highlighting the setting button 326 and indicating the script "Interval" above the setting button 326. In response to selecting the cough pause interval setting 326, increase button 328 and decrease button 330 are presented for the user to select and adjust the value of the current cough interval condition for the currently selected interval step (currently set to 10 minutes). Figure 38 and Figure 39 This indicates that the user has switched the enable switch 320 and the auto-restart switch 322 to the on position to enable their features.

[0144] Now refer to Figure 40 The user has selected the Add Programs tab 224 to open the preset treatment conditions control interface (shown as Therapy 2) to add a new preset treatment, for example, from any screen 214, 258, 300. In the illustrative embodiment, the user selects the Add Programs tab 224 to automatically proceed to the unlock settings state, but in some embodiments, selecting the Add Programs tab 224 may require confirmation to unlock the settings and / or may be unavailable without unlock settings.

[0145] In response to the user selecting the Add Program tab 224, screen 332 is displayed to open the preset treatment condition control interface for the new current treatment, allowing the user to configure additional current treatments, such as "Therapy 2" as the next available series of preset treatment settings. The user can select and adjust the preset treatment settings for Treatment 2 in a similar manner to that described above regarding Treatment 1, such as interval, frequency, intensity, duration, cough pausing, etc. After successfully creating a new current treatment, an additional treatment tab is added between tabs 222 and 224, allowing the user to select the Treatment 2 tab in the corresponding screen. Accordingly, multiple preset treatment plans can be preset for the user to select and / or modify.

[0146] Now refer to Figure 41The user has selected, for example, the settings button 225 available on screen 258. In response to the user's selection of settings button 225, GUI 58 proceeds to device settings screen 334. Device settings screen 334 presents settings tabs 336, 338, 340 and a GUI version toggle switch 342. The settings tabs include a device information tab 336, which presents information about the force generator 16, such as, but not limited to, model identification information, performance information, software / firmware information (e.g., the latest updated version and / or date) and / or user device registration information. The settings tabs include a service tab 338, which the user can select to present service information about the force generator 16, such as, but not limited to, information about service history, recommended services and / or service facility identification and / or contact information. The settings tabs include a management tab 340, which the user can select to present management information about the force generator 16, such as application management regulations, compliance and / or resource information.

[0147] The GUI version switch 342 includes two modes: a basic mode as illustrated and described above, and an advanced mode. The advanced mode is illustratively represented as a more complex mode with additional and / or more granular options for selective adjustments, including wireless communication configuration, power control options, and / or related operations less frequently used by the patient during surgery. The user toggles the GUI version switch 342 to access the advanced mode, and can return to the basic mode by toggling the GUI version switch 342 again.

[0148] Now refer to Figures 42 to 44 An exemplary arrangement of the force generator 16 is shown. Figure 42 The image shows a force generator 16 having a housing 5000 and a top-mounted handle 5002 integrated with the housing 5000. The handle 5002 is illustratively fixed to the housing 5000. (See reference...) Figure 43 The image shows a force generator 16 with a housing 6000 similar to the housing 5000, but with a foldable handle 6002 fixed to the top. The handle 6002 can be folded by pivoting to the rear side of the housing 6000. Figure 44 The diagram shows a force generator 16 having another housing 7000 and an outer cover 7002, the outer cover 7002 having a handle 7004 extending across the top of the housing 7000. The outer cover 7002 is embodied as a sleeve surrounding the exterior of the housing 7000, having the handle 7004 integrally formed therewith. The outer cover 7002 and the handle 7004 are illustratively formed of a resilient, flexible material. The handle 7004 can be shaped to provide a shoulder strap for carrying the force generator 16.

[0149] Now refer to Figure 45 and Figure 46The image shows a pump assembly 512 of the force generator 16, with the external portions of the force generator 16 removed for disclosure. The pump assembly 512 illustratively includes a pressurized housing 514 and a piston assembly disposed within the pressurized housing 514 to generate pressure. The pressurized housing 514 includes a piston chamber 518 for receiving a piston 516 to generate pressure and a pressurized outlet 520 for transmitting pressure to the garment 14.

[0150] Piston chambers 518 are illustratively arranged on opposite sides of the pressure housing 514, extending longitudinally parallel to allow for parallel piston strokes. Each piston 516 is arranged in its respective piston chamber 518 to perform reciprocating motion to generate pressure. Each piston 516 is closely spaced from the wall 522 (and may include piston rings to tightly control the spacing), thereby defining the respective piston chamber 518 to [perform a reciprocating motion]. Figure 45 and Figure 46 Pressure is generated on the pressure side 524 during the reciprocating motion in the lateral direction. The pressure side 524 of each piston chamber 518 is arranged to communicate with the outlet 520 so as to connect to the garment 14.

[0151] Reference Figure 46 The drive motor 526 is coupled to two pistons 516 to drive reciprocating motion. The drive motor 526 includes a rotary drive shaft 528 for providing rotary drive. The pistons 516 are coupled to the drive shaft 528 via corresponding linkage mechanisms 530.

[0152] Now refer to Figure 47 Each linkage 530 is operably connected to a drive shaft 528 to convert rotational drive of the drive shaft 528 into reciprocating motion of a corresponding piston 516. Each linkage 530 includes an eccentric cam member 532 coupled to the drive shaft 528 to rotate with it. Each drive linkage 530 includes a link support 534, one end of which is pivotally connected to the corresponding piston 516 and coupled to the corresponding cam member 532 to transmit reciprocating motion, such that transmission occurs even when the cam member 532 has no rotational movement.

[0153] In the illustrative embodiment, each link support 534 is coupled to a corresponding cam member 532 via a cylindrical yoke 536 formed on the end of the link support 534 opposite to the end connected to the corresponding piston 516. The cylindrical yoke 536 of each link support 534 receives the corresponding cam member 532 therein, illustratively having a sliding bearing arrangement to convert the rotary cam motion into reciprocating piston drive. The cam members 532 are arranged to be offset from each other in rotational positions relative to the drive shaft 528, such that the pistons 516 move synchronously away from and towards the drive shaft 528.

[0154] During each outward stroke of piston 516, a negative pressure is created to be transmitted to vest 14 through outlet 520, and during each inward stroke of piston 516, a positive pressure is created to be transmitted to vest 14 through outlet 520. The positive and negative pressures from piston operation can be controlled by pressure valves to communicate with vests, or appropriately routed via check valves.

[0155] Now refer to Figure 48 Another illustrative pump unit 612 of the force (pressure) generator 16 is shown. Pump unit 612 is similar to pump unit 512, and the disclosure of pump unit 512 also applies to pump unit 612, unless it contradicts the specific disclosure of pump unit 612. Similar to pump unit 512, pump unit 612 includes: a pressure housing including a piston chamber; and two pistons 616, each arranged in a respective piston chamber for reciprocating motion to generate pressure on the pressure side 617 of the piston 616 to be transmitted to vest 14.

[0156] Pump unit 612 includes a drive shaft 620 arranged to provide drive for pistons 616 by rotational drive via a drive motor 621. Each piston 616 is coupled to the drive shaft 620 via a drive linkage mechanism 622. Each drive linkage mechanism 622 includes a radial link 624 fixed at one end to the drive shaft 620 and coupled to the corresponding piston 616 at the opposite end. In an illustrative embodiment, each radial link 624 is formed by a single member connected to the drive shaft 620 near its center. Each radial link 624 includes a cam member 626 arranged at the opposite end for engaging with the corresponding piston 616 to drive reciprocating motion.

[0157] The cam member 626 of each radial link 624 is arranged within the yoke rail 628 of the corresponding piston 616. The cam member 626 of each radial link 624 is arranged to travel along the corresponding yoke rail 628 under the rotation of the drive shaft 620, to convert the rotational motion of the drive shaft 620 into reciprocating motion to drive the corresponding piston 616. The drive shaft 620 operates to rotate in a first direction to drive the pistons 616 outwards to generate negative pressure, and in a second direction opposite to the first rotational direction to drive the pistons 616 inwards to generate positive pressure. To provide bidirectional rotation of the drive shaft 620, a stepper motor with position feedback about the drive shaft 620 can be used.

[0158] Now refer to Figure 49Another pump unit 712 is shown. Pump unit 712 includes a pressurization assembly as part of force generator 16. The pressurization assembly includes a positive pressure port 714 for providing positive pressure to vest 14 and a negative pressure port 716 for providing negative pressure to vest 14. Pump unit 712 illustratively includes a positive pressure pump 718 and a negative pressure pump 720, but in some embodiments, a single pump may generate both positive and negative pressure simultaneously. Pumps 718, 720 are arranged to selectively communicate with ports 714, 716 via pressure control assembly 722.

[0159] The pressure control assembly 722 includes a pressure control device for continuously supplying positive and negative pressure to the vest 14. The pressure control assembly 722 illustratively includes a housing 724 defining two pressure flow paths 726, 728, each pressure flow path 726, 728 having one end connected to a corresponding port 714, 716 and the other end connected to a corresponding pump 718, 720, such that flow path 726 is a positive flow path and the other flow path 728 is a negative flow path. The pressure control assembly 722 includes positive and negative side control bodies 730 arranged in each flow path 726, 728 for selectively operating to deliver corresponding positive and negative pressure to the vest 14.

[0160] Each control body 730 includes a flow channel 732 defined therethrough, selectively arranged to communicate with corresponding flow paths 726, 728 in an open-flow position to allow pressure transfer to the vest 14, and selectively arranged to be non-communicating with corresponding flow paths 726, 728 in a closed-flow position to prevent pressure transfer to the vest 14. Each flow channel 732 is arranged with opposite ends such that rotation in one direction establishes two angular orientations including open-flow positions.

[0161] The control bodies 730 are arranged such that their flow channels 732 are not parallel to each other, so that only one of positive or negative pressure is allowed at a given time. More specifically, during rotation, the angular position of the flow channel 732 of each control body 730 about its axis of rotation is offset to be approximately perpendicular to each other. The control bodies 730 are all illustratively fixed to the same rotary drive shaft 736 driven by a rotary drive motor 734 to provide continuous rotation, thereby continuously transmitting positive and negative pressure to the vest 14 to provide oscillatory therapy according to the treatment control system 46.

[0162] The control unit 730 is illustratively shaped as an oblate spheroid. The flow channel 732 of each control unit 730 illustratively extends through the longitudinal dimension of the control unit 730. The operation of each of the pump units 512, 612, and 712 is illustratively controlled according to the treatment control system, including according to settings and / or inputs as described with respect to GUI 58.

[0163] Now refer to Figure 51The default screen 5012 (screen 01A) of GUI 58 is shown. The default screen 5012 is illustratively represented as the initial screen that appears after the timeout of the introductory screen 212, as part of the other screen operations (e.g., with...). Figure 20 The screen operations associated with screen 214 are alternatives to those associated with default screen 5012 and screen 214, but in some embodiments, screen operations associated with one or both of default screen 5012 and screen 214 can be combined in any suitable manner to support HFCWO operations. Default screen 5012 and its associated screen operations are similar to screen 212 and its associated screen operations, and the disclosure of screen 212 and its associated screen operations also applies to default screen 5012 and its associated operations, unless it contradicts the specific disclosure of default screen 5012 and its associated operations.

[0164] On screen 5012, GUI 58 presents multiple tab options, including tabs 5014 and 5016, as indicated by the bold text of tab 5014 and its continuous connection to the rest of screen 5012 (right side). Tab 5014 is currently selected. The currently selected tab 5014 presents a treatment start button 5018 and the currently set HFCWO settings 5020, including frequency (12), intensity (4), and duration (20 minutes). The currently selected HFCWO treatment settings are illustratively applied as the default settings for the currently selected treatment regimen. In some arrangements, the HFCWO system dynamically determines the settings during treatment, for example, based on the determination of the user's breathing as described above, determining dynamic changes in the settings to decrease the frequency and / or intensity values ​​during inspiration and / or increase the frequency and / or intensity values ​​during expiration, for example, to enhance patient comfort while maintaining treatment effectiveness. In some embodiments, a dynamic toggle switch may be provided by GUI 58 for user activation to, for example, to toggle the dynamic HFCWO setting control on and off for any given treatment regimen.

[0165] In screen 5012, GUI 58 is presented in a title bar 5022 visible across multiple screens. The title bar 5022 illustratively includes a vendor icon 5024, a system lock button 5026 indicating the current lock arrangement via a graphic illustration of a closed padlock, and a wireless communication indicator 5028. The wireless communication indicator 5028 illustratively includes a WiFi indicator 5030 and a Bluetooth indicator 5032, both used to indicate the availability of their respective connection types.

[0166] Now refer to Figure 52On screen 5012A, the user can unlock GUI 58 for adjustments by activating system lock button 5026. After initially selecting system lock button 5026, illustratively, by touching or nearly touching system lock button 5026, system lock button 5026 is slightly enlarged and drag trajectory 5034 is displayed to indicate to the user the drag direction and range to activate unlock.

[0167] On screen 5012B, the user has begun sliding the system lock button 5026 along the drag path 5034. Approximately halfway through this range, the unlock button 5036 appears below the initial position of the system lock button 5026. (See reference...) Figure 53 On screen 5012C, the user has dragged the system lock button 5026 to the range of drag trajectory 5034, thereby activating the unlock function of GUI 58 to adjust the HFCWO system parameters. After the user releases the system lock button 5026, the unlock is complete, allowing the system lock button 5026 to spring back to its initial position, returning to screen 5012. After unlocking is complete, proceed to screen 1B, as described in this article... Figure 56 Detailed explanation.

[0168] Brief Review Figure 51 On screen 5012, GUI 58 presents a pull-tab 5038. The pull-tab 5038 is illustratively arranged along the outer edge on the right-hand side of screen 5012 and includes a spherical tab protruding from the bottom of an elongated shape, which overlaps with other background details of screen 5012 to indicate to the user, by engaging with the pull-tab 5038, that additional information is available. (See reference...) Figure 54 On screen 5040, from any screen where the pull tab 5038 is available, the pull tab 5038 is activated by the user engaging the pull tab 5038 (e.g., by touch or near touch) and dragging the pull tab 5038 (to the left) to the extended position to expand the base bottom to display additional information. Other buttons / tabs with drag operations in this disclosure operate similarly to button 5026 and tab 5038. In some embodiments, the drag action of the pull tab / button can be accomplished by quickly tapping the tab / button. On screen 5040, the pull tab 5038 includes a home button 5092. If the GUI 58 state is locked, the user activates the home button 5092 to return to screen 5012 (screen 01A), or if the GUI 58 state is unlocked, the user activates the home button 5092 to return to screen 5066, as described herein. Figure 56 Detailed explanation.

[0169] Still refer to Figure 54The user can close the pull tab 5038 by touching or nearly touching the ball-shaped end and dragging the pull tab 5038 (to the right) to its closed position to proceed to screen 5042 (screen 01A.11). Screen 5042 is the playback screen, which can be activated from screen 5012 (or any screen available from the treatment start button 5018) by activating the treatment start button 5018, as shown on the left side of screen 5042 (in...). Figure 51 Similar to reference mark B on the right side of screen 5012. Figures 51 to 74 Additional reference markers in the image indicate the operation between images. On screen 5042, the treatment start button 5018 is slightly smaller and includes a treatment interval indicator 5044 embodied as a cycle time indicator.

[0170] On screen 5042, a cough pause button 5048 is displayed for the user to activate, pausing the treatment to allow the user to cough without being hindered by the impact of the treatment. (Brief reference) Figure 52 By activating the cough pause button 5048 (e.g., by touch or near-touch to display the drag path 5047) and dragging the cough pause button 5048 to the opposite end of the drag path 5047, the cough pause can be toggled between an on and off state. When the cough pause button is deactivated, its color may darken, such as... Figure 52 As shown by the slashes in the diagram. Deactivating the cough pause button 5048 may cause the pre-defined pause in the treatment plan to be skipped, thus maintaining the treatment operation.

[0171] review Figure 54 The user activates the treatment start button 5018 on screen 5042 to begin treatment and proceeds to screen 5042A (screen 01A.12). The treatment interval indicator 5044 of the treatment start button 5018 indicates that 16 minutes and 28 seconds of the initial 27-minute time slot remain, as written in the script on screen 5042A, and as the equivalent portion of the cycle time indicator is reduced to a dashed line instead of a thick solid bar. When the treatment interval is currently running, the treatment start button 5018 changes from a play symbol to a pause symbol (with two vertical bars). Referring to screen 5042B (screen 01A.14A), after the user activates the pause symbol of the treatment start button 5018 by touch or near-touch, the treatment interval is paused, and the treatment interval indicator 5044 changes to a pause timer indicator 5044. A stop interval button 5049 is presented for the user to choose to optionally stop the interval period, and the pause symbol of the treatment start button 5018 returns to a play symbol.

[0172] On screen 5042B, the treatment zone indicator 5044 has been changed to indicate the pause count, including a loop timer that counts the pause periods. The user selects the play symbol on the treatment start button 5018 to restart the treatment zone and return to screen 5042A. However, if the pause lasts for a longer period, such as a total pause of 10 minutes, screen 5042B proceeds to... Figure 55 The GUI 58 presents screen 5050 (screen 01A.14B). After a pause of an exemplary 10 minutes, the GUI 58 presents screen 5052 (screen 01A.15), including an indication 5054 that treatment time has been missed (remaining treatment time determined as the pause time). Screen 5052 includes: a resume button 5056, which the user can activate to resume the treatment interval and return to screen 5042A; and an exit button 5058, which the user can activate to terminate the current treatment plan and return to screen 5012.

[0173] According to screen 5042A ( Figure 54 This allows for automatic completion of the treatment interval to proceed to the next stage. Figure 55 The GUI 5060 displays a completion message 5062 and presents a home button 5064 for the user to activate to return to screen 5012. If no user input is received within a 10-minute timeout window, the GUI 58 automatically returns to screen 5012.

[0174] Reference Figure 56 This shows the initial unlock screen 5066 (screen 01B). See above for reference. Figures 52 to 53 Screens 5012A to 5012C describe unlocking GUI 58 for adjustments by activating the system lock button 5026. These screens proceed to screen 5066, where the system lock button 5026 changes from a locked padlock symbol to an unlocked padlock symbol. Unlocking GUI 58 presents the Edit Treatment button 5068 for user activation to allow editing of treatment plans. As shown below screen 5066, the user selects the Edit Treatment button 5068, for example by touch or near-touch, and a drag path 5071 is presented to invite the user to drag the Edit Treatment button 5068 to the opposite side (right) of the drag path to activate the Edit Treatment button 5068.

[0175] In response to user activation of the edit treatment button 5068, GUI 58 proceeds to... Figure 57Screen 5070 is shown. On screen 5070 (screen 01B.11), the HFCWO setting 5020 of Treatment Plan 1 is enabled as setting buttons 5072, 5074, and 5076, which can be activated by the user to allow adjustment of the corresponding parameters. The setting buttons include: frequency button 5072, which can be activated by the user to adjust the impact frequency; intensity button 5074, which can be activated by the user to adjust the impact intensity; and duration button 5076, which can be activated by the user to adjust the treatment duration.

[0176] exist Figure 57 On screen 5073 (screen 01B.12), the user has activated frequency button 5072, as shown by extending the settings label to connect frequency button 5072 and changing the script "SETTINGS" to "FREQUENCY". In response to activating frequency button 5072, GUI 58 enables increase button 5078 for user activation to increase the frequency setting and enables decrease button 5080 for user activation to decrease the frequency setting, as shown. Figure 58 As shown on screen 5086 (screen 01B.12.01).

[0177] exist Figure 57 On screen 5082 (screen 01B.13), the user activates the intensity button 5074, as shown by the setting label extending to connect the intensity button 5074 and changing the corresponding script to "INTENSITY". In response to the activation of the intensity button 5074, GUI 58 enables the increase button 5078 for the user to activate to increase the intensity setting and enables the decrease button 5080 for the user to activate to decrease the intensity setting.

[0178] Brief Reference Figure 59 On screen 5082 (screen 01B.14), the user activates the duration button 5076, as shown by extending the settings label to connect the duration button 5076 and changing the corresponding script to "DURATION". In response to the activation of the duration button 5076, GUI 58 enables the increase button 5078 for the user to activate to increase the duration setting and enables the decrease button 5080 for the user to activate to decrease the duration setting.

[0179] For example, a user can activate the treatment start button 5018 from any screen (5070, 5073, 5082) to begin treatment. Figure 57As shown on screen 5084 (screen 01B.21), the treatment interval indicator 5044 of the treatment start button 5018 indicates that 16 minutes and 28 seconds of time remain, as written in the script, or as the equivalent portion of the cycle time indicator is reduced to a dashed line instead of the thick solid bar on screen 5084. When a treatment interval is currently running, the treatment start button 5018 changes from a play symbol to a pause symbol (with two vertical bars). In response to the user activating the treatment start button 5018 by touch or near-touch, the stop interval button 5049 is presented for the user to select to stop the interval period, and the pause symbol of the treatment start button 5018 returns to a play symbol.

[0180] While the treatment zone is in operation, the user can activate the cough pause button 5048 from screen 5084 (screen 01B.21) to initiate a predetermined periodic pause in the application of therapeutic force to the patient, allowing unobstructed coughing to, for example, clear and / or expel material from the airway. After activation, the cough pause button 5048... Figure 59 The pause screen 5088 indicates the start of a predetermined periodic automatic pause interval for treatment. Users can activate the pull tab 5038 from the pause screen 5088 to adjust the cough pause parameters.

[0181] like Figure 59 As shown, activating the pull tab 5038 presents several menu options, including a home button 5092 for the user to return to screen 5066 (screen 1B), a cough pause settings button 5094 for the user to adjust cough pause parameters, and a delete treatment button 5096 (requires confirmation) for the user to delete the current treatment. The user activates the cough pause settings button 5094 to proceed to screen 5098 (screen 01B.42).

[0182] exist Figure 59 On screen 5098, the user activates the cough pause setting button 5094, as shown by the highlighted button image and the pull tab 5038 responsively extending to display the cough pause parameters 5100. The cough pause parameters 5100 include: an enable switch 5102 for user activation to enable adjustment of the pause duration interval and intermittent periods; and an auto-restart switch 5104 for user activation to toggle on / off automatic restart of the treatment cycle after the cough pause cycle ends, without user confirmation before the treatment cycle resumes. The cough parameters 5100 also include: a duration interval button 5108 for user activation to adjust the predetermined pause duration interval; and a cough intermittent period button 5110 for user activation to adjust the predetermined time interval between cough pauses.

[0183] The user activates the cough pause setting button 5108 to proceed to... Figure 60 Screen 5112 (Screen 01B.44) is shown as follows: the top script is connected to button 5108, and the script is changed from "SETTINGS" to "INTERVAL". On screen 5112, increase button 5114 and decrease button 5116 are enabled for user activation to increase or decrease the predetermined cough duration interval, which is the duration of the pause in therapeutic force for each cough pause. Follow step button 5111 is presented for user activation to toggle the on / off control to provide cough pauses between interval steps of the treatment plan.

[0184] The user activates the cough interval button 5110 to proceed to... Figure 62 The screen 5118 shown is a screen 01B.45. On screen 5118, the increase button 5114 and the decrease button 5116 are enabled for the user to activate to increase or decrease the predetermined cough interval, which is the duration between cough pauses.

[0185] Brief Review Figure 59 On screen 5098, the user activates enable switch 5102 to proceed to... Figure 61 On screen 5120 (screen 01B.43), the duration interval button 5108 and the cough interval period button 5110 are deactivated, as shown in the slash. The increase button 5114 and the decrease button 5116 are removed. The user (re)activates the enable switch 5102 to return to screen 5098 and reactivates the duration interval button 5108 and the cough interval period button 5110 for the user to select.

[0186] User activates homepage button 5092 (e.g.) Figure 59 (In the middle) proceed to screen 5122 (screen 01B.51) to present Figure 61 The drag path 5124 is shown. The user can drag the home button 5092 to the opposite end of the drag path 5124 to activate the home button 5092 and proceed to screen 5126 to expand the pull tab 5038 to present a confirmation request. The confirmation request asks the user whether they should save the cough pause parameters and presents a "Yes" confirmation button 5128 and a "No" confirmation button 5130. The user selects either the "Yes" confirmation button 5128 or the "No" confirmation button 5130 to return to screen 1066, either with or without saving the cough pause parameters.

[0187] When tab 5038 is expanded, the user (deactivates) the cough pause setting button 5094; when tab 5038 is retracted, it returns to... Figure 59 The user can activate enable switch 5102 by pulling up a tab 5038 from, for example, screen 5098 to proceed to... Figure 61Screen 5120. As an example of various screen operations in this disclosure, although already from... Figure 59 Screen 5098 activates enable switch 5102, but screen 5120 can still be accessed by activating cough pause setting button 5094. Accordingly, predetermined cough pauses can be implemented and / or adjusted within the treatment plan.

[0188] Brief Review Figure 51 The user activates tab 5016 to activate GUI 58, docking additional treatment plans and proceeding to... Figure 63 The screen shown is 5134 (screen 01C). The settings menu 5136 indicates the predetermined treatment parameters for the additional treatment program, which illustratively includes 6 total treatment steps and a total treatment time of 18 minutes. When the additional treatment program is running, the user activates the treatment start button 5018 to begin the shock therapy according to the additional treatment program and proceeds to screen 5138 (screen 01C.11).

[0189] exist Figure 63 On screen 5138, in response to the user selecting treatment start button 5018, when the additional treatment protocol is running, the size of treatment start button 5018 is reduced and includes treatment interval indicator 5044, which is embodied as a segmented cycle time indicator, including a segment 5140 for each predetermined step of the additional treatment protocol. Treatment protocol step indicator 5142 is presented as a semi-circular line with step indicator 5144 and step selection buttons 5146, 5148. Since indicator 5144 corresponding to step 1 is at the horizontal level, the currently selected step is step 1. The currently selected step can be emphasized by bolding, highlighting, coloring and / or any other suitable visual indicator, and the HFCWO setting 5020 corresponding to step 1 is displayed (shown as frequency 12, intensity 4 and duration 3). The user activates step selection buttons 5146, 5148 to navigate to other steps of the protocol.

[0190] The user activates the treatment start button 5018 on screen 5138 to activate the currently selected additional treatment step and proceed to... Figure 64 On screen 5150, the treatment start button 5018 has changed its play symbol to a pause symbol, indicating that an additional treatment program is in progress and 4 minutes and 32 seconds of the total treatment time has elapsed.

[0191] Since the step 2 indicator 5144 is at the horizontal level, it indicates the second step of the currently selected treatment plan. The currently selected step can be emphasized by bolding, highlighting, coloring, and / or any other suitable visual indicator. The HFCWO setting 5020 corresponding to step 2 is displayed (shown as frequency 13, intensity 5, and duration 3). A segment 5140 of the treatment interval indicator 5044 corresponding to the second step of the treatment plan is displayed with a portion presented as a dashed line and a portion presented as a thick solid line, such that the dashed line portion indicates the elapsed time of step 2 and the thick solid line indicates the remaining time in step 2.

[0192] After the user activates the pause symbol on the treatment start button 5018, the current treatment operation is paused and GUI 58 proceeds to screen 5152 (screen 01C.22A). The treatment start button 5018 changes to a play symbol, the treatment interval indicator 5044 changes to count the amount of time spent in the pause, and the time script indicates that a pause of 1 minute and 21 seconds has elapsed. On screen 5154 (screen 01C.22B), the pause can continue until the user activates the play symbol to restart the treatment, or continue until the pause timer expires (e.g., a pause of 10 minutes). Figure 65 Screen 5156 (screen 01C.23) is shown. After a pause of an exemplary 10 minutes, GUI 58 presents screen 5156, including an indication 5158 that treatment time has been missed (remaining treatment time determined as the pause time). Screen 5156 includes: a resume button 5056, which the user can activate to resume the treatment interval and return to screen 5150; and an exit button 5058, which the user can activate to terminate the current treatment plan and return to screen 5012.

[0193] review Figure 64 After all steps of the treatment plan are completed, GUI 58 proceeds to screen 5160 (screen 01C.13). A completion message 5162 is provided and a home button 5164 is presented for the user to activate and return to screen 5012. If no action is taken within the 10-minute timeout window, GUI 58 automatically returns to screen 5012.

[0194] Users can Figure 64 Screen 5154 activates the step selection button 5146 to increase the selected step level. Move to Figure 66On screen 5166 (screen 01C.24), the user has increased the selected step level to level 3, as indicated by the horizontal position of step 3 indicator 5144. HFCWO setting 5020 has been changed to the predetermined setting indicating step 3. However, even when step 3 is selected for display, step 2 of the treatment plan is currently in progress, as indicated by the script of the pause symbol on treatment start button 5018. Step 2 has elapsed for 1 minute and 32 seconds, and step 2 indicator 5144 remains, indicating its current operation through bolding, highlighting, coloring, and / or any other suitable visual indicator. The user selects step selection button 5146 to increase the currently selected step to step 4 to proceed to screen 5168 (screen 01C.25), which displays HFCWO setting 5020 corresponding to step 4. The user selects step selection button 5148 to decrease the currently selected step to proceed to screen 5166, and then proceeds sequentially to screen 5150 according to the number of activations.

[0195] Reference Figure 67 As shown by the lock button 5026 displaying the unlock padlock symbol, when GUI 58 unlocks, the user selects tab 5016 to activate the additional treatment plan and proceeds to screen 5170 (screen 01D), where the Edit Treatment button 5068 is presented. The settings menu 5136 illustratively indicates the current settings of the additional treatment plan as 6 steps and 18 minutes. A clothing button 5172 is presented for the user to activate to change the indication of the relevant clothing, such as by clothing model. The user activates the Treatment Start button 5018 to begin the additional treatment plan and proceeds to screen 5178 (screen 01D.01XX). The user selects the Edit Treatment button 5068 to present a drag path 5174, which the user can drag to the opposite end of to activate the Edit Treatment button 5068 and proceed to screen 5176 (screen 01D.01), allowing adjustment of the additional treatment plan settings.

[0196] Similar to the editing treatment settings for Treatment Plan 1, on screen 5176 (screen 01D.01), the HFCWO settings 5020 for Treatment Plan 2 are enabled as setting buttons, including: a frequency button 5072 for user activation to adjust the impact frequency; an intensity button 5074 for user activation to adjust the impact intensity; and a duration button 5076 for user activation to adjust the treatment duration. However, in the editing mode of the advanced treatment plan (Treatment Plan 2), HFCWO settings can be pre-defined for each individual step of the treatment plan. For example, the currently selected step 1 is indicated by its horizontal position on the treatment plan step indicator 5142, and its settings include frequency 12, intensity 4, and duration 3. The user can activate the step selection buttons 5146 and 5148 to navigate to other steps, such as the add step button 5146 to proceed to screen 5178 (screen 01D.11).

[0197] On screen 5178, when the step 2 indicator is currently selected, the user can activate any of the settings buttons 5072, 5074, or 5076 to adjust the preset parameters of the relevant settings, such as... Figure 68 As shown. Users can activate the frequency button 5072, intensity button 5074, or duration button 5076 by touching or nearly touching the corresponding buttons 5072, 5074, and 5076, and proceed to screens 5180, 5182, and 5184. Figure 70 The selected setting is adjusted by activating the increase button 5078 and the decrease button 5080. For example, the user activates the frequency button 5072 and the increase button to adjust the setting. Figure 69 The screen 5183 indicates that the frequency setting in step 2 should be increased to 13.

[0198] The user activates the pull tab 5038 to expand it, revealing the home button 5092, the cough pause button 5094, and the delete button 5096, as follows: Figure 70 As shown on screen 5185 (01D.21A). The user selects the home button 5092 to proceed to... Figure 71 The screen 5222 displays a drag path 5223 to allow the user to drag the home button 5092 to activate the home action and proceed to screen 5226. Activating the home action causes the expandable pull tab 5038 to display a save settings prompt, along with a yes button 5228 and a no button 5230 to save or not save the settings respectively, after which the user returns to screen 5170. Figure 67 The user (deactivates) the pull tab 5038 to return to screen 5184.

[0199] Reference Figure 68The user can activate another pull tab 5186 to expand it onto the display to show additional information, as shown on screen 5188 (screen 01D.31). Pull tab 5186 includes: an Add Step button 5190, which the user can activate to add a new step to the additional treatment plan; and a Delete Step button 5192, used to remove the currently selected step from the additional treatment plan. The user selects the Add Step button 5190 to proceed to... Figure 70 The screen 5194 (screen 01D.32) displays a drag path 5196, allowing the user to drag the Add Step button 5190 to the opposite end of the drag path 5196 to activate the Add Step button 5190 and proceed to screen 5198 (screen 01D.33) to further expand the pull tab 5186 to display additional information.

[0200] exist Figure 70 On screen 5198, drag tab 5186 to expand and display new step options 5200, including: settings 5210 for the user to select the HFCWO settings for the new step; an indicator 5212 indicating the new step inserted as step 3; and a confirm button 5214 and a cancel button 5216 for the user to activate to create a new step or cancel step creation, respectively. The user activates the cancel button 5216 to return to screen 5194. Settings 5210 includes a frequency button 5218, an intensity button 5220, and a duration button 5224, all of which are activated by the user to allow adjustment of the corresponding value settings by activating the increase button 5225 and the decrease button 5227, currently indicating frequency 12, intensity 3, and duration 3, while selecting the corresponding settings in a similar manner to adjusting existing step settings. The user activates the confirm button 5214 to add a new step with the currently selected settings and proceeds to... Figure 72 Screen 5232 (screen 01D.34) indicates that the newly created step 3 has added 1 minute of the total treatment duration to the 18 minutes of the previous 6 steps, as indicated by treatment interval indicator 5044, for a total of 19 minutes and 7 steps.

[0201] The user's deletion step is illustrated on screen 5234 (01D.35), where the user activates a drag-and-drop tab 5186 to display the Add Step button 5190 and the Delete Step button 5192. The user activates the Delete button 5192 to proceed to screen 5236, which presents a confirmation prompt regarding the deletion of the current step, along with a Yes button 5238 and a No button 5240 for the user to activate to confirm or deny the deletion, respectively. The user activates the No button 5240 to return to screen 5234. The user activates the Yes button 5238 to confirm the deletion of the selected step and proceed to... Figure 73 The screen is 5242 (01D.37).

[0202] exist Figure 73 On screen 5242, the pull tab 5186 includes a message indicating that the step has been deleted. The user (deactivates) the pull tab 5186 or a timeout (e.g., 5 minutes) causes a return to... Figure 68 The screen is 5178, and appropriate steps are taken to adjust it.

[0203] Brief Reference Figure 70 On screen 5185, the drag-and-drop tab 5038 is activated to display the home button 5092, the cough pause settings button 5094, and the delete treatment button 5096. The user selects the delete treatment button 5096 to proceed to... Figure 73 The screen 5244 displays the drag trajectory. The user can drag the delete treatment button 5096 to the opposite side of the drag trajectory to activate the delete treatment button 5096 and proceed to the screen 5246.

[0204] On screen 5246, the drag-and-drop tab 5038 is further expanded to display a confirmation script for deleting a treatment and instructions for deleting the selected treatment, such as Therapy Two. A Yes button 5248 and a No button 5250 are presented for the user to activate to confirm or deny the deletion of the treatment plan, respectively. Upon saving settings, whether the treatment plan is deleted or not, the user returns to screen 5170. Figure 67 ).

[0205] Reference Figure 74 For clarity, screen 5170 (screen 01D) is displayed again. The user activates the pull tab 5038 by touching or nearly touching it, expanding the pull tab and proceeding to screen 5260 (screen 01E). The expanded pull tab 5038 displays the device settings button 5262, the add treatment button 5264, and the delete treatment button 5266. The user activates the add treatment button 5264 to proceed to screen 5268 (screen 01F).

[0206] On screen 5268, in response to user activation of the Add Treatment button 5264, an additional treatment plan has been added, as shown in the additional tab 5270, labeled "Therapy Three". The newly created Therapy Three plan has the same preset settings as the treatment plan currently selected when the user activated the Add Treatment button 5264, such as Therapy Two, which has 6 steps and a total duration of 18 minutes, as shown in the settings menu 5136. When the Therapy Three tab 5270 is selected, the tab 5038 is activated and the Delete Treatment button 5266 is activated, which deletes the Therapy Three plan and returns to screen 5260.

[0207] The user activates the cough pause setting button 5262 to proceed to... Figure 75 Screen 5272 (Screen 02A) is shown. On screen 5272, GUI 58 presents a device settings platform 5274. The device settings platform includes multiple tabs 5276, 5278, 5280, 5282, and 5284 that can be activated by the user. Currently, the device settings tab 5276 is selected, as indicated by the additional information to the right of tab 5276 and by tab 5276 being highlighted, colored, and / or having any other appropriate visual indicators that distinguish it from other tabs. Activating the device settings tab 5276 presents sub-tabs, including the main sub-tab 5286, the language sub-tab 5288, and the security sub-tab 5290.

[0208] On screen 5272, the currently selected main sub-tab 5286 displays various options, including GUI version option 5292, brightness option 5294, and clothing size option 5296. GUI version option 5292 includes a toggle switch 5298 for user activation to switch between a basic and advanced version of the graphical user interface. Brightness option 5294 includes a slider 5302 (currently at the fourth brightness level) for user to position along the linear range of brightness option 5294 to set the brightness of GUI 58. Clothing size option 5296 includes a toggle switch 5304 for user activation to toggle the consideration of therapeutic clothing size on and off when applying various HFCWO operation settings. For example, pressure levels may differ between children's and adult sizes; when clothing size option 5296 is on, HFCWO can more accurately take clothing size into account when deploying impact.

[0209] The user activates the language sub-tab 5284 to proceed to screen 5306 and invoke the language options. The language options include buttons 5308 for various languages. Currently, button 5308 corresponding to English is selected, and the user can activate another language (currently unfilled) as the default language by touching or nearly touching the corresponding button 5308. A next-page button 5310 is presented for the user to activate to pan to another page of language buttons 5308 on screen 5312 (screen 02A.11), which then changes the next-page button 5310 to a back button 5314 for the user to activate to pan back to screen 5306. The user activates the language button to proceed to... Figure 76 Screen 5312 (screen 02A.11) displays a confirmation window and an indication 5316 of the newly selected default language. An OK button 5318 and a Cancel button 5320 are presented for the user to activate to accept or reject the default language change, respectively.

[0210] Brief Review Figure 75 The user activates the Device Information tab 5278 to proceed to screen 5315 (screen 02B) to display Device Information 5317. The Device Information descriptively includes the device model, serial number, control board information (e.g., control board software number, bootloader version), FCC information, Bluetooth version, and total treatment runtime.

[0211] The user activates the connection tab 5282 to proceed to screen 5324 (screen 02D) and invokes the connection options, such as... Figure 77 As shown. Connection options include a WiFi sub-tab 5326 and a Bluetooth sub-tab 5328. On screen 5324, with the WiFi sub-tab 5326 currently selected, the WiFi options include: a WiFi toggle switch 5330 for the user to activate to toggle the WiFi connection on / off; a WiFi settings button 5331 for the user to activate to adjust WiFi settings; and a WiFi network list 5332.

[0212] The WiFi network list 5332 includes: an indication of the currently connected WiFi network; a network settings button 5334 for the user to activate and adjust various settings of the current network connection; a disconnect button 5336 for terminating the current network connection; a list of other available WiFi networks 5338 for the user to activate and connect to the corresponding WiFi network; and a scroll bar 5340 for the user to scroll through the list of other available WiFi networks 5338.

[0213] The user activates the Bluetooth sub-tab 5328 to access screen 5342 and invoke the Bluetooth options. The Bluetooth options include: a Bluetooth toggle switch 5344, which the user can activate to toggle the Bluetooth connection on and off; a Bluetooth settings button 5346, which the user can activate to adjust various Bluetooth connection settings; and an add connection button 5348, which the user can activate to create a new Bluetooth connection.

[0214] exist Figure 78 In the GUI 58, a QWERTY keyboard 5350 and / or a numeric keypad 5352 can be presented for user activation to easily input text and numbers. In response to user activation of the relevant text / numeric input field, the keyboard 5350 and / or the numeric keypad 5352 can be overlaid on the current screen.

[0215] In this disclosure, the HFCWO technique is capable of expelling mucus from the bronchial walls. The mechanism by which mucus is expelled may involve applying air oscillations to the lungs, causing a decrease in mucus viscosity, and additional airflow shear as the primary mechanisms. During HFCWO, airflow bias may also occur, pushing mucus from the peripheral airways towards the central airways. Increased chest wall compression during expiration results in higher peak expiratory flow rates and a greater difference between mean expiratory and mean inspiratory flow rates, i.e., better therapeutic effects. During inspiratory expiration, HFCWO may be less effective and may lead to poorer user comfort. Chest pressure can be reduced during user inspiration. Improved HFCWO can be provided by offering feedback mechanisms, such as user breathing patterns, and controlling the air pump generator to change pressure output during inspiration and expiration.

[0216] To acquire a user's breathing patterns in a way that is comfortable and / or easy to use for the patient, a micro-electro-mechanical system (MEMS) can be combined with a three-axis accelerometer, a three-axis gyroscope, and / or a three-axis magnetometer to provide a miniaturized nine-axis motion tracking device. Such a device can be integrated with a digital processor on the same chip to process complex sensor fusion algorithms that provide three-dimensional motion reconstruction. Based on this, breathing indications can be captured through motion. Bluetooth can be used for wireless data transmission and / or feeding information back to mobile devices, such as smartphones. Therefore, small, portable devices (motion sensors) can be mounted on a vest / backpack for collecting breathing data. Information can be transmitted to a pump force generator to change the pressure output for patient comfort. If necessary, one or more motion sensors can be waterproof.

[0217] Additionally, respiratory rate has been shown to predict adverse clinical events such as cardiac arrest. Respiratory pattern data / motor activity can also be collected to assess pulmonary ventilation function (e.g., respiratory rate and tidal volume), a sub-indicator of lung health.

[0218] To ensure user comfort, traditional systems may lack feedback capabilities and / or may lack consideration of the user's breathing patterns when controlling pressure output. Additionally, breathing information can be used for pre-diagnosis of the user's lung health or potential risks. Accordingly, the software / firmware implements the conversion of motion sensor readings into breathing patterns and adjusts / matches the pressure output from the air pulse generator to the user's baseline breathing pattern, thus enhancing HFCWO treatment.

[0219] Although certain exemplary embodiments have been described in detail above, variations and modifications exist within the scope and spirit of this disclosure as described and defined in the claims.

Claims

1. A chest wall oscillation therapy system, comprising: a chest engagement device to deliver an impact force to a patient's chest; a force generator arranged to generate a continuous impact force as a treatment regimen for the patient, the force generator arranged in communication with the chest engagement device to deliver the impact force from the force generator to the patient's chest to facilitate airway clearance; and a therapy control system including at least one sensor arranged to detect an indication of a patient's breathing pattern; the therapy control system arranged to dynamically configure the force generator treatment regimen in accordance with data from the at least one sensor, including, for each inhalation and exhalation cycle of the patient, decreasing an oscillation rate of the impact force while the patient is inhaling, and then, in response to inhalation ceasing, increasing the oscillation rate of the impact force while the patient is exhaling, wherein an active treatment of the treatment regimen is delivered for at least a portion of time to deliver the impact force during inhalation, wherein the therapy control system configures the force generator to have an inhalation setting for the oscillation rate during inhalation of the patient that is less than an exhalation setting for the oscillation rate during exhalation of the patient. the at least one sensor includes at least one microelectromechanical sensor.

2. The chest wall oscillation therapy system of claim 1, wherein, the at least one sensor is arranged to provide at least nine-axis tracking of patient chest movement.

3. The chest wall oscillation therapy system of claim 1, wherein, the at least one sensor includes at least one accelerometer.

4. The chest wall oscillation therapy system of claim 1, wherein, the at least one sensor includes at least one gyroscope.

5. The chest wall oscillation therapy system of claim 1, wherein, the at least one sensor includes at least one magnetometer.

6. The chest wall oscillation therapy system of claim 1, wherein, the therapy control system includes at least one processor to provide a motion profile based on data received from the at least one sensor.

7. The chest wall oscillation therapy system of claim 1, wherein, the at least one sensor is mounted to the chest engagement device to detect movement of the patient's chest.

8. The chest wall oscillation therapy system of claim 2, wherein, the therapy control system is arranged to communicate with a personal mobile device to convey the patient chest indication.

9. The chest wall oscillation therapy system of claim 1, wherein, the therapy control system includes a graphical user interface for communicating with a user.

10. The chest wall oscillation therapy system of claim 1, wherein, the graphical user interface is arranged to present selectable options available for selection by the user.

11. The chest wall oscillation therapy system of claim 10, wherein, the selectable options available for selection by the user include an oscillation start button to initiate an operation to provide the impact force to the patient.

12. The chest wall oscillation therapy system of claim 11, wherein, in response to the user selecting the oscillation start button, the graphical user interface presents a pause button as a selectable option.

13. The chest wall oscillation therapy system of claim 12, wherein, the selectable options available for selection by the user include a new preset regimen button for the user to create a new preset regimen as the treatment regimen to implement.

14. The chest wall oscillation therapy system of claim 12, wherein, the selectable options available for selection by the user include an unlock button, wherein, in response to the user selecting the unlock button, at least one of a frequency button, an intensity button, and a time button are presented as selectable options available for selection by the user to configure a corresponding feature.

15. The chest wall oscillation therapy system of claim 12, wherein, the selectable options available for selection by the user include a preset regimen tab to implement a preset regimen as the treatment regimen.

16. The chest wall oscillation therapy system of claim 12, wherein, in response to the user selecting at least one of the preset regimen tab and the unlock button, a cough pause tab is presented for selection by the user to configure a cough pause setting of the preset regimen.

17. The chest wall oscillation therapy system of claim 16, wherein, in response to the user selecting the cough pause tab, at least one of a cough pause enable switch and an automatic restart switch are presented for selection by the user.

18. The chest wall oscillation therapy system of claim 17, wherein, ​ 19. The chest wall oscillation therapy system of claim 18, wherein, In response to a user selecting the cough pause enable switch to confirm a cough pause, presenting at least one of a pause duration button and a pause frequency button for user selection to adjust the associated presented enable switch and the auto-restart switch for user selection to configure the respective feature.

20. The chest wall oscillation treatment system of claim 1, wherein, The chest engagement device comprises a wearable garment.

21. The chest wall oscillation treatment system of claim 1, wherein, The therapy control system configures the force generator to have an exhalation setting of at least one of a shock rate and an impact force intensity during patient exhalation that is greater than a predetermined nominal setting of the at least one of a shock rate and an impact force intensity.

22. The chest wall oscillation therapy system of claim 21, wherein, The therapy control system configures the force generator to have an inhalation setting of at least one of a shock rate and an impact force intensity during patient inhalation that is less than the exhalation setting during patient exhalation.

23. The chest wall oscillation therapy system of claim 22, wherein, The inhalation setting is less than or equal to the predetermined nominal setting.

24. The chest wall oscillation treatment system of claim 1, wherein, The therapy control system configures the force generator to have an inhalation setting of at least one of a shock rate and an impact force intensity during patient inhalation that is less than a predetermined nominal setting of the at least one of a shock rate and an impact force intensity.

25. The chest wall oscillation therapy system of claim 24, wherein, The therapy control system configures the force generator to have an exhalation setting of at least one of a shock rate and an impact force intensity during patient inhalation that is greater than the inhalation setting during patient inhalation.

26. The chest wall oscillation therapy system of claim 25, wherein, The inhalation setting is greater than or equal to the predetermined nominal setting.

27. The chest wall oscillation treatment system of claim 11, wherein, The selectable options include a pull tab for user activation to present additional selectable options, wherein the additional selectable options include at least one of a home button, a cough pause settings button, and a delete therapy button.

28. The chest wall oscillation treatment system of claim 14, wherein, The new predetermined therapy regimen button is accessible by user activation of a pull tab to expand the new predetermined therapy regimen button.

29. The chest wall oscillation treatment system of claim 15, wherein, User activation of the unlock button includes dragging the unlock button to a predetermined range.

30. The chest wall oscillation treatment system of claim 29, wherein, The chest engagement device comprises a wearable garment, and the therapy control system comprises a garment size toggle switch operable for user selection between an on position in which the therapy control system adapts configuration of the force generator to account for a size of the wearable garment and an off position in which the therapy control system does not adapt configuration of the force generator to account for the size of the wearable garment.

Images